Trends in Endocrinology & Metabolism
ReviewHepatic FXR: key regulator of whole-body energy metabolism
Section snippets
FXR discovery and characterization
The farnesoid X receptor (FXR; NR1H4) is a member of the nuclear receptor superfamily and a receptor for bile acids (BAs) 1, 2, 3. FXR binds to FXR response elements [4] either as a monomer or as a heterodimer with the retinoid X receptor (RXR) 5, 6 and promotes transcription of target genes. There are two genes encoding FXR [7], FXRα and FXRβ. FXRα is expressed from a single gene locus in humans and rodents that encodes four different isoforms (resulting from different promoters and RNA
FXR in disease
Diabetes is one of the leading causes of morbidity and mortality in the world (Diabetes Atlas, Regional Overview, http://www.diabetesatlas.com/content/regional-overview). The liver plays a vital role in the maintenance of adequate circulating glucose levels because it is the principal organ for gluconeogenesis and glycogen synthesis [17]. Modulation of FXR activity represents a valid and interesting strategy for combating pernicious effects of several BA-related pathologies, diabetes and other
FXR and lipid metabolism
FXR is an important regulator of lipid metabolism 12, 13, 14, 15, 16. In FXR-deficient mice, serum high-density lipoprotein (HDL) cholesterol and TG levels are elevated, whereas hepatic expression of the HDL receptor scavenger receptor class-B1 (SRB1), which facilitates HDL cholesterol removal from the blood [30], is decreased. FXR also regulates gene expression of proteins involved in lipid metabolism, such as phospholipid transfer protein (PLTP) and apolipoprotein (apo) C-II, which are
Adipokines
Changes in adipose tissue metabolism are intimately related to obesity and insulin resistance. This tissue is responsible for the production of several physiologically active molecules known as adipokines. Examples include leptin, resistin, interleukin (IL)-6, tumor necrosis factor (TNF)-α, plasminogen-activator inhibitor type 1 (PAI-1), resistin and adiponectin (AdipoQ) 41, 42, 43. AdipoQ expression is decreased in obesity, whereas TNF-α, IL-6 and leptin are increased, with mixed reports for
PPARα
FXR regulates the expression of PPARα, a key regulator of lipid metabolism, and its target genes [51]. PPARα agonism increases fatty acid oxidation, lipolysis, energy uncoupling and expenditure, while decreasing lipogenesis, TG secretion and adiposity [52]. Interestingly, there is evidence suggesting that PPARα might activate FXR expression [19], although conflicting evidence remains. For example, in C57BL/6J and KK-Ay mice treated with cholic acid, there was no increase in expression of genes
FXR deficiency in hyperglycemia
FXR expression is decreased in rodent models of diabetes 62, 63. Glucose stimulates FXR expression, whereas insulin represses it [63]. At physiological concentrations, insulin also represses Cyp7a1 [64], which potentially explains the increase in BA synthesis in diabetes that is associated with decreased FXR expression. Taking this into account, it is not surprising that FXR activation leads to decreased glucose levels in wild-type and two diabetic strains (KK-Ay and db/db) of mice 21, 50, 65.
Concluding remarks
Despite being mostly expressed in the liver, FXR is a potent regulator of the metabolic status of an organism. Undoubtedly, FXR agonism causes alterations in several metabolically involved organs where it is not particularly expressed, and changes their energy metabolism profile. Whether it is a positive or negative effect seems to depend on the model used and modus operandi of the experimental procedure. However, the majority of literature seems to point to the fact that FXR activation is
Acknowledgments
J.S. Teodoro is the recipient of a grant from Fundação para a Ciência e a Tecnologia (SFRH/BD/38467/2007).
References (93)
Endogenous bile acids are ligands for the nuclear receptor FXR/BAR
Mol. Cell
(1999)Identification of the DNA binding specificity and potential target genes for the farnesoid X-activated receptor
J. Biol. Chem.
(2000)Identification of a nuclear receptor that is activated by farnesol metabolites
Cell
(1995)FXR, a multipurpose nuclear receptor
Trends Biochem. Sci.
(2006)Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors
Mol. Cell
(2000)Natural structural variants of the nuclear receptor farnesoid X receptor affect transcriptional activation
J. Biol. Chem.
(2003)Effects of cholestyramine and chenodeoxycholic acid on the metabolism of endogenous triglyceride in hyperlipoproteinemia
J. Lipid Res.
(1978)- et al.
Triglyceride-lowering effect of chenodeoxycholic acid in patients with endogenous hypertriglyceridaemia
Lancet
(1974) Chenodeoxycholic acid for hypertriglyceridaemia
Lancet
(1976)Potential regulatory role of the farnesoid X receptor in the metabolic syndrome
Biochimie
(2005)
Studies on LXR- and FXR-mediated effects on cholesterol homeostasis in normal and cholic acid-depleted mice
J. Lipid Res.
Differential alterations in mitochondrial function induced by a choline-deficient diet: understanding fatty liver disease progression
Mitochondrion
FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats
J. Lipid Res.
The farnesoid X-receptor is an essential regulator of cholesterol homeostasis
J. Biol. Chem.
The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression
J. Biol. Chem.
Identification of PLTP as an LXR target gene and apoE as an FXR target gene reveals overlapping targets for the two nuclear receptors
J. Lipid Res.
Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression
Gastroenterology
Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression
J. Lipid Res.
Coordinated control of bile acids and lipogenesis through FXR dependent regulation of fatty acid synthase
J. Lipid Res.
Adipose tissue as an endocrine organ
Trends Endocrinol. Metab.
The metabolic syndrome and adipocytokines
FEBS Lett.
Syndecan-1 expression is regulated in an isoform-specific manner by the farnesoid-X receptor
J. Biol. Chem.
The farnesoid X receptor regulates adipocyte differentiation and function by promoting peroxisome proliferator activated receptor-γ and interfering with the Wnt/β-catenin pathways
J. Biol. Chem.
The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice
J. Biol. Chem.
The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation
Biochim. Biophys. Acta
LXRs regulate the balance between fat storage and oxidation
Cell Metab.
Loss of functional farnesoid X receptor increases atherosclerotic lesions in apolipoprotein E-deficient mice
J. Lipid Res.
Differential effects of streptozotocin-induced diabetes on expression of hepatic ABC-transporters in rats
Gastroenterology
Insulin suppresses bile acid synthesis in cultured rat hepatocytes by down-regulation of cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase gene transcription
Hepatology
Glucose transporter gene expression: regulation of transcription and mRNA stability
Pharmacol. Ther.
Bile acids regulate gluconeogenic gene expression via small heterodimer partner-mediated repression of hepatocyte nuclear factor 4 and Foxo1
J. Biol. Chem.
Glucocorticoid signaling is perturbed by the atypical orphan receptor and corepressor SHP
J. Biol. Chem.
Perturbation of fuel homeostasis caused by overexpression of the glucose-6-phosphatase catalytic subunit in liver of normal rats
J. Biol. Chem.
A potential link between peroxisome proliferator-activated receptor-alpha signaling and obesity-related diabetes
Cell Metab.
The nuclear receptor FXR is expressed in pancreatic β-cells and protects human islets from lipotoxicity
FEBS Lett.
The bile acid sensor FXR regulates insulin transcription and secretion
Biochim. Biophys. Acta
Bile acid reduces the secretion of very low density lipoprotein by repressing microsomal triglyceride transfer protein gene expression mediated by hepatocyte nuclear factor-4
J. Biol. Chem.
Regulation of pyruvate dehydrogenase kinase expression by the farnesoid X receptor
Biochem. Biophys. Res. Commun.
The farnesoid X receptor modulates the carbohydrate metabolism during the fasting–refeeding transition
J. Biol. Chem.
Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis
Cell
Identification of a nuclear receptor for bile acids
Science
Bile acids: natural ligands for an orphan nuclear receptor
Science
Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors
Mol. Endocrinol.
The farnesoid X receptor. A molecular link between bile acid and lipid and glucose metabolism
Arterioscler. Thromb. Vasc. Biol.
Identification of farnesoid X receptor β as a novel mammalian nuclear receptor sensing lanosterol
Mol. Cell Biol.
Bile acid metabolism in hereditary forms of hypertriglyceridemia: evidence for an increased synthesis rate in monogenic familial hypertriglyceridemia
Proc. Natl. Acad. Sci. U.S.A.
Cited by (103)
FXR/ASS1 axis attenuates the TAA-induced liver injury through arginine metabolism
2022, Biochemical and Biophysical Research CommunicationsL-Theanine regulates lipid metabolism by modulating gut microbiota and bile acid metabolism
2023, Journal of the Science of Food and Agriculture